| Literature DB >> 35486196 |
Marco M Herz1, Nora Celebi2, Thomas Bruckner3, Valentin Bartha4.
Abstract
OBJECTIVES: Plaque control by improved domestic oral hygiene is essential in periodontal treatment. However, changing treatment providers may interfere with building a dentist-patient relationship and in turn affect treatment success. The aim of this randomized, controlled, prospective short-term study was to determine the influence of either one or four different pre-graduate practitioners on patients' oral hygiene parameters during active periodontal therapy.Entities:
Keywords: Dental students; Gingival bleeding; Oral hygiene; Periodontitis; Plaque control
Mesh:
Year: 2022 PMID: 35486196 PMCID: PMC9381624 DOI: 10.1007/s00784-022-04501-1
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.606
Characteristics of participating dental students
| Characteristics | All students | Students CT group | Students DT group | |
|---|---|---|---|---|
| Gender | Female | 28 | 12 | 16 |
| Male | 27 | 15 | 12 | |
| Age (years) | 26.5 ± 3.5 | 27.4 ± 3.9 | 25.6 ± 2.9 | |
Fig. 1CONSORT flow diagram. The dental students were randomized into the treatment groups. Patients were allocated so that their prognostic factors were evenly distributed among the groups
Patient characteristics
| Characteristics | All patients | CT group | DT group | |
|---|---|---|---|---|
| Continuous treatment | Discontinuous treatment | |||
| Gender | Female | 22 | 11 | 11 |
| Male | 33 | 16 | 17 | |
| Age (years) | 54.9 ± 9.2 | 55.7 ± 9.9 | 54.0 ± 8.6 | |
| Smoking | Yes | 25 | 14 | 11 |
| No | 30 | 13 | 17 | |
| Diabetes mellitus | ||||
| Pocket depth | = 4–6 mm [%] | 14.5 | 14.7 | 13.6 |
| > 6 mm [%] | 5.0 | 5 | 4.7 | |
| Microbiological test | Type 4 or 5 | |||
| Type 1, 2 or 3 | ||||
| Interleukin-1 test | Risk A + B | |||
| Risk C + D | ||||
Pocket depth:
• = 4-6 mm [%]: Average proportion of pockets in the group with a pocket depth between 4 and 6 mm
• > 6 mm [%]: Average proportion of pockets in the group with a pocket depth > 6 mm
Microbiological test:
• type 4 or 5: Number of patients whose microbiological test results correspond with type 4 or 5
• type 1, 2, or 3: Number of patients whose microbiological test results correspond with type 1, 2 or 3
Interleukin-1 test:
• risk A + B: Number of patients with normal reaction to inflammation or reduced anti-inflammatory effect
• risk C + D: Number of patients with strong or excessive inflammatory reaction and increased or highly increased genetic risk of infection
Fig. 2Treatment sessions and time intervals between the treatment sessions
Papilla bleeding index for scoring
| 0 | No bleeding |
| 1 | One bleeding point |
| 2 | Several bleeding points or one thin bleeding line |
| 3 | Interdental triangle filled with blood |
| 4 | Profuse bleeding, blood spreads towards the marginal gingiva |
Fig. 3Formulas for calculating PBI, PCR, and BOP
Fig. 4Triangles representing the probing locations for assessing BOP
Fig. 5Papilla bleeding index (PBI), bleeding on probing (BOP) and plaque control record (PCR), and the relative number of patients that showed improvement or non-improvement in group DT (discontinuous treatment) and CT (continuous treatment)
Quantile-scores (in %), inter-group ∆, and intra-group p-values of the DT group (discontinuous treatment) and the CT group (continuous treatment)
| Parametre | Group | ∆ T1-T2 | Session I | Session IV | ∆ Inter-group | Intra-group | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | % | % | ||||||||||
| median | 25 | 75 | median | 25 | 75 | median | 25 | 75 | ||||
| BOP | DT | 3.33 | 16.56 | 23.03 | 47.90 | 11.88 | 33.10 | 0.919 | < 0.001 | |||
| CT | 2.16 | 20.71 | 19.61 | 62.30 | 6.40 | 36.90 | < 0.001 | |||||
| PCR | DT | 6.28 | 46.03 | 58.35 | 80.03 | 25.67 | 58.60 | 0.333 | < 0.001 | |||
| CT | 5.55 | 26.1 | 45.23 | 78.37 | 22.50 | 62.50 | < 0.001 | |||||
| PBI | DT | -1.18 | 15.95 | 6.87 | 34.77 | 4.56 | 20.56 | 0.117 | 0.027 | |||
| CT | 3.57 | 22.2 | 13.22 | 44.19 | 2.90 | 28.33 | < 0.001 | |||||
Correlation analysis of age, BOP, PBI, and PCR for the DT group and the CT group
| Variable | With variable | Group DT | Group CT | ||
|---|---|---|---|---|---|
| Spearman | Spearman | ||||
| ∆ BOP | Age | -0.1136 | 0.5649 | 0.1939 | 0.3325 |
| ∆ PCR | Age | -0.0233 | 0.9064 | -0.0606 | 0.7642 |
| ∆ PCR | ∆ BOP | 0.1648 | 0.4021 | 0.2766 | 0.1626 |
| ∆ PBI | Age | -0.0762 | 0.7000 | -0.1234 | 0.5397 |
| ∆ PBI | ∆ BOP | 0.1716 | 0.3825 | 0.5853 | 0.0013 |
| ∆ PBI | ∆ PCR | 0.1084 | 0.5830 | 0.2183 | 0.2740 |